• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
COVID-19 in a melanoma patient under treatment with checkpoint inhibition.一名正在接受检查点抑制治疗的黑色素瘤患者感染了新冠病毒。
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e465-e466. doi: 10.1111/jdv.16661. Epub 2020 Jul 6.
2
Pyrexia by COVID-19 in a patient treated with dabrafenib/trametinib therapy.一名接受达拉非尼/曲美替尼治疗的患者因新型冠状病毒肺炎出现发热。
J Dermatol. 2021 Feb;48(2):e122-e123. doi: 10.1111/1346-8138.15696. Epub 2020 Nov 16.
3
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.抗 PD-1 治疗的癌症患者中 SARS-CoV2 感染的病程：病例报告和文献复习。
Cancer Invest. 2021 Jan;39(1):9-14. doi: 10.1080/07357907.2020.1844893. Epub 2020 Nov 6.
4
The best treatments to use after checkpoint inhibition in melanoma.黑色素瘤经检查点抑制治疗后的最佳治疗方法。
Clin Adv Hematol Oncol. 2017 Apr;15(4):242-245.
5
Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus.在一名患有落叶型天疱疮的黑色素瘤患者中使用免疫检查点抑制剂且无病情加重。
Int J Dermatol. 2017 Dec;56(12):1477-1479. doi: 10.1111/ijd.13713. Epub 2017 Aug 1.
6
Definite regression of cutaneous melanoma metastases upon addition of topical contact sensitizer diphencyprone to immune checkpoint inhibitor treatment.在免疫检查点抑制剂治疗中加入外用接触致敏剂二苯环丙烯酮后，皮肤黑色素瘤转移灶出现明确的消退。
Exp Dermatol. 2016 Jul;25(7):553-4. doi: 10.1111/exd.13030.
7
Digital ischemia triggered by coronavirus disease 2019 in a patient under cemiplimab treatment.一名接受西米普利单抗治疗的患者出现由2019冠状病毒病引发的手指缺血。
Int J Dermatol. 2021 Jan;60(1):e30-e32. doi: 10.1111/ijd.15239. Epub 2020 Oct 11.
8
Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。
Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.
9
Pembrolizumab (Keytruda°) and metastatic or inoperable melanoma.帕博利珠单抗（可瑞达°）与转移性或不可切除的黑色素瘤
Prescrire Int. 2017 May;26(182):118-119.
10
Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?检查点抑制剂对于转移性或不可切除的外阴和阴道黑色素瘤来说是一种有价值的选择吗？
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):e39-e40. doi: 10.1111/jdv.14486. Epub 2017 Aug 13.

引用本文的文献

1
Immune checkpoint inhibitors in cancer patients with COVID-19.新冠病毒病（COVID-19）癌症患者中的免疫检查点抑制剂
Open Life Sci. 2023 Jul 7;18(1):20220641. doi: 10.1515/biol-2022-0641. eCollection 2023.
2
SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibitors.癌症患者接受免疫检查点抑制剂治疗时的 SARS-CoV-2 感染和 COVID-19 疫苗接种。
Cell Death Dis. 2023 Jun 30;14(6):390. doi: 10.1038/s41419-023-05922-w.
3
Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection.抗 PD-1 封锁对 SARS-CoV-2 感染的潜在保护作用。
Biomed Pharmacother. 2021 Oct;142:111957. doi: 10.1016/j.biopha.2021.111957. Epub 2021 Jul 28.
4
Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era.COVID-19 大流行期间肿瘤学中免疫检查点抑制剂管理的利弊
Cancers (Basel). 2021 Apr 15;13(8):1906. doi: 10.3390/cancers13081906.
5
Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients.肝脏肿瘤的经皮微波消融应用：针对新冠肺炎患者的建议
Heliyon. 2021 Mar 6;7(3):e06454. doi: 10.1016/j.heliyon.2021.e06454. eCollection 2021 Mar.
6
Treating COVID-19 Positive Cancer Patients With Radiation Therapy: A Case Report From Epicenter of the Pandemic.用放射治疗新冠病毒检测呈阳性的癌症患者：来自疫情中心的病例报告。
Cureus. 2020 Dec 8;12(12):e11967. doi: 10.7759/cureus.11967.
7
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection.SARS-CoV-2感染时代的癌症与免疫检查点抑制剂治疗
Cancers (Basel). 2020 Nov 16;12(11):3383. doi: 10.3390/cancers12113383.
8
[Not Available].[无可用内容]
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-809. doi: 10.1111/ddg.14169_g.
9
COVID-19 and immunological regulations - from basic and translational aspects to clinical implications.COVID-19 与免疫调控：基础与转化医学到临床应用
J Dtsch Dermatol Ges. 2020 Aug;18(8):795-807. doi: 10.1111/ddg.14169. Epub 2020 Aug 6.

本文引用的文献

1
The many faces of the anti-COVID immune response.抗新冠病毒免疫反应的多面性。
J Exp Med. 2020 Jun 1;217(6). doi: 10.1084/jem.20200678.
2
Skin cancer triage and management during COVID-19 pandemic.COVID-19 大流行期间的皮肤癌分诊和管理。
J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1136-1139. doi: 10.1111/jdv.16529.
3
CoViD-19 Immunopathology and Immunotherapy.新型冠状病毒肺炎的免疫病理学与免疫治疗
Bioinformation. 2020 Mar 31;16(3):219-222. doi: 10.6026/97320630016219. eCollection 2020.
4
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
5
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors.关于新型冠状病毒肺炎和使用免疫检查点抑制剂进行抗癌治疗的争议。
Immunotherapy. 2020 Apr;12(5):269-273. doi: 10.2217/imt-2020-0067. Epub 2020 Mar 26.
6
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
7
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.一种在中国出现的新型冠状病毒——影响评估的关键问题
N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.

COVID-19 in a melanoma patient under treatment with checkpoint inhibition.

作者信息

Schmidle P, Biedermann T, Posch C

机构信息

Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany.

Faculty of Medicine, Sigmund Freud Universität Wien, Wien, Austria.

出版信息

J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e465-e466. doi: 10.1111/jdv.16661. Epub 2020 Jul 6.

DOI:10.1111/jdv.16661
PMID:32455475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7283722/
Abstract
摘要